Sign in
CompletedNo phase

Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD

Key facts

Who runs it
VA Office of Research and Development
Where
Palo Alto, United StatesSee the site
Trial code
Status
Completed
People taking part
76 people enrolled
Started
1 Jan 2017
Ended
31 Dec 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CBT-OSA
  • Sleep Education
Record updated
29 July 2024

Who can take part

Age
18 years to 99 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Male or Female Veterans of any racial or ethnic group
  • Age 18 years old and older
  • OSA diagnosis by a board-certified Sleep Medicine physician
  • Have PTSD
  • Capable of giving informed consent for the study; able to read and write English; willing and able to comply with study requirements and restrictions
  • Not have a cognitive disorder
  • Sufficient visual and auditory acuity for cognitive testing
  • No new medication(s) within the prior 1 month. If on a non-excluded medication for a non-excluded condition, the medication regimen will be stable (no changes in dose) for at least 1 month prior to baseline (including anti-hypertensive and diabetic medications)

Who cannot take part

  • Current CPAP usage, home oxygen therapy, tracheotomy or past corrective surgery for OSA (e.g., uvulopalatopharyngo-plasty, midline glossectomy, or lingualplasty)
  • Any current clinically significant cardiovascular, respiratory, neurologic, hepatic, hematopoietic, renal, gastrointestinal or metabolic dysfunction unless currently controlled and stable. Any solid organ transplantation
  • Certain medications
  • Comorbid sleep disorder
  • Unstable or moderate to severe chronic illness including systolic congestive heart failure, uncontrolled asthma, severe liver disease, end stage renal disease requiring hemodialysis or history of systemic illness affecting central nervous system (CNS) function (e.g. liver failure, kidney failure, congestive heart failure, systemic cancer)
  • Known or suspected neuromuscular disease (e.g. amyotrophic lateral sclerosis, spinal cord injury)
  • History of head injury within past year, or history of loss of consciousness > 24 hours
  • History of other neurological disease
  • Judged by the investigators to be unable or unlikely to follow the study protocol; Psychiatric
  • Primary psychotic disorder
  • Bipolar disorder
  • Presence of acute or unstable psychiatric condition(s) that requires referral for treatment
  • Current or expected cognitive behavior therapy for another condition (e.g. insomnia, anxiety); Other
  • Sleep
  • Diagnosis of Central Sleep Apnea (CSA)
  • Working night, rotating or split [period of work, followed by break, and then return to work]; shift work within 1-month of screening or plan to work these shifts during study; Occupations where participants regularly experience jet lag or have irregular work schedules; Other Medical
  • Prominent suicidal or homicidal ideation
  • Current exposure to trauma, or exposure to trauma in the past 3 months
  • Some substance use
  • A clinical history or participation in other research that would interfere with the objectives of this study
  • Any other medical, social, or geographical factor that would make it unlikely that the participant would comply with the study procedures

Where in United States

  • VA Palo Alto Health Care System, Palo Alto, CAPalo Alto, United States

About the trial

What the trial wants to find out

Approximately 20 million Americans suffer from Obstructive Sleep Apnea (OSA) creating risks for major health problems, including dementia, heart attack, and stroke. Obesity, a growing problem for Americans and Veterans alike, is the greatest risk factor for the development of OSA. Male gender and smoking, other OSA risk factors, are common in Veterans. Given the high comorbidity of these risk factors in Veterans, OSA presents a significant health burden to Veterans. The investigators' prior work provides evidence that OSA occurs in up to 69% of Vietnam-era Veterans with Posttraumatic Stress Disorder (PTSD). OSA is easily treated; however, 15-30% of OSA patients are non-compliant with continuous positive airway pressure (CPAP), the standard OSA treatment. The proposed research aims to facilitate adherence to CPAP treatment by testing a novel cognitive-behavioral therapy intervention in Veterans with PTSD. If successful, it may represent an approach that could be applied to the rehabilitation of other chronic conditions with similar barriers to care.

The 2 groups in the trial

  • CBT-OSATreatment being tested

    CBT-OSA is a new cognitive behavioral therapy which focuses on changing behaviors and thoughts to help individuals adjust to using a CPAP machine.

  • Sleep EducationExisting treatment, for comparison

    The Sleep Education treatment will include information, facts, and videos on sleep, cardiovascular disease, PTSD, and proper sleep hygiene.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
29 July 2024